Antipsychotic use and unexpected death: a hospital-based case-control study

Area of Science:

• Psychiatry and Pharmacology
• Public Health and Epidemiology

Background:

• Antipsychotic medications are widely prescribed for various mental health conditions.
• Understanding the safety profile, particularly regarding mortality risk, is crucial for clinical decision-making.

Purpose of the Study:

• To investigate the association between antipsychotic prescription and the risk of unexpected death.
• To define unexpected death as mortality occurring within seven days of acute symptom onset.

Main Methods:

• A UK-based case-control study was conducted between July 2009 and January 2011.
• Included 100 cases of unexpected death and 436 unmatched controls from a mental health trust.

Main Results:

• Current antipsychotic users showed a significantly lower risk of unexpected death (adjusted OR 0.48).
• Second-generation antipsychotics were associated with a reduced risk (adjusted OR 0.42), while first-generation agents showed no significant difference (adjusted OR 0.83).
• Treatment duration, dose, and route of administration did not impact risk.

Conclusions:

• The study findings do not support a link between current antipsychotic use and an elevated risk of unexpected death.
• Antipsychotic use, especially second-generation agents, may be associated with a reduced risk of sudden mortality.